Sino Biological, Inc.

Join Sino Biological at the Association for Diagnostics & Laboratory Medicine 2024 Annual Meeting! As an exhibitor, we're excited to connect with you and discuss how our innovative products can elevate your research. Visit our booth to: 💡Discover our latest diagnostic solutions and products 💡Get expert insights from our team 💡Learn how our offerings can streamline your lab processes Don't miss this opportunity to network with industry leaders and find the diagnostic solutions your lab needs. We look forward to seeing you at booth 5128! Interested in meeting one-on-one? Schedule a meeting here: https://ow.ly/k4ez50SzHz6 #ADLM2024 #Diagnostics #LabMedicine

Discover the potential of Claudin 18.2 in precision medicine. From its physiological role in gastric epithelium to its emergence as a novel target for innovative cancer treatments, explore how this molecule is reshaping oncology research in our newest video! #CancerResearch #Claudin18 #Oncology

Recent studies highlight the potential of the CD2-CD58 axis as a therapeutic target to enhance anti-tumor immune response. Notable therapies include FDA approved Siplizumab, used for type 1 diabetes and transplant rejection, and Alefacept, approved for psoriasis treatment. Sino Biological offers a range of recombinant CD2 and CD58 proteins and antibodies to support research and therapeutic development. Learn more in our newsletter below! #Immunotherapy #CancerResearch #AutoimmuneDiseases

Join us for a webinar in partnership with GenoBioTx on "Advances in ADC: Development and Preclinical Models" by Dr. hua wei. 🗓️ Date: Wednesday, August 7th 🕑 Time: 2PM CT / 3PM ET Dr. hua wei, VP of the Industrial Clients Department at GenoBioTx/Shanghai Model Organisms Center (USA), LLC, will share insights into the latest advancements in antibody-drug conjugates (ADCs) and the critical role of preclinical models. Register now to secure your spot: https://ow.ly/fv7n50Swcbw #Webinar #Biotechnology #Pharmaceuticals #ADC #PreclinicalModels #BiotechEvents

Receptor tyrosine kinases (RTKs) play a crucial role in normal cellular functions and cancer progression. Targeted treatments using monoclonal antibodies and small molecule drugs have achieved significant success in cancer therapy. Notable examples include FDA-approved ALK inhibitors for non-small cell lung cancer, as well as ongoing clinical trials investigating AXL, c-Kit, and c-Met inhibitors across a spectrum of malignancies. Interested in learning more about the latest research in cancer therapy? Subscribe to our newsletter below! #CancerTherapy #RTKs #CancerResearch

We at SignalChem embody the true Canadian values of unity, diversity, and innovation. Our multicultural team proudly reflects the rich tapestry that is Canada, showcasing strength in diversity. As we stand by our customers, we commit to delivering excellence and integrity in all we do. We are proudly Canadian, moving forward together in scientific discovery. Happy Canada Day! #canadaday #canadaday2024 #canada #diversity #diversityintheworkplace

Introducing Mohammad S. Safiarian, Associate Manager in the Product & Marketing team. With a background in pharmacy and biochemistry, Mohammad brings a wealth of knowledge to our team, driven by a passion for personalized cancer therapies. At Sino, Mohammad focuses on market research, product performance analysis, and creating marketing materials that resonate with our customers. He is excited about the potential of personalized therapies to transform cancer treatment, minimizing side effects and maximizing effectiveness. His advice to fellow scientists? Stay curious and embrace new challenges. Mohammad is also excited about CRISPR-based gene editing, a groundbreaking development in gene therapy. Outside the lab, Mohammad finds joy in reading about and working on cars. Want to join our team? Visit our careers page: https://ow.ly/gFC450SsW2I #EmployeeSpotlight #Innovation #Biotech

📢 Last Chance to Get 20% Off* on Organoid Culture Cytokines! 🧫 Elevate your research with our premium-grade cytokines, renowned for their validated bioactivity, batch-to-batch consistency, and purity. Trusted by leading researchers worldwide, our products ensure proven quality and superior performance. Explore our range of cytokines: https://lnkd.in/gz82Jycf *Available only to US/CAN end-users until June 30 #OrganoidCulture #OrganoidCytokines #Cytokines

Nanobodies, or single-domain antibodies, offer unparalleled potential in immunotherapy and beyond. Derived from camelids and cartilaginous fish, they have properties like high specificity, stability, and low immunogenicity. Sino Biological has developed a cutting-edge nanobody development platform, harnessing phage antibody libraries to deliver candidates. From antigen preparation to humanization, our one-stop custom services ensure seamless nanobody R&D and production. Service Highlights: ▪️ Diverse screening methods: solid-phase, liquid-phase, cell panning ▪️ Flexible strategies: subtractive, competitive, and cross-screening ▪️ Advanced identification techniques: FACS, ELISA, SPR/BLI, and more Learn more and contact us for a quote today: https://ow.ly/vPqB50SqcgP #Nanobodies #NanobodyProduction #AntibodyProduction

ADC development is complex, involving challenges from target selection to linker stability. At Sino Biological, we specialize in tailored solutions to simplify your journey. Our catalog includes ADC target proteins, MMPs, Cathepsins, and uPA for linker cleavage studies. Essential for PK and ADA assays, we offer high-quality anti-idiotypic antibodies, Fc receptors, and anti-payload antibodies. Our CRO services span early discovery to clinical research, providing comprehensive support for your ADC project's success. Discover how we can elevate your ADC development process: https://ow.ly/u2wJ50SqbHj #ADCDevelopment #AntibodyDrugConjugate #AntibodyDevelopment